Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Syros Pharmaceuticals , a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced the grant of a restricted...

Related Keywords

,Syros Pharmaceuticals ,Linkedin ,Nasdaq Listing Rule ,Stock Incentive ,Markets ,